GSK plc

Common Name
GSK
Country
United Kingdom
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
68,629
Ticker
GSK
Exchange
LONDON STOCK EXCHANGE
Description
GSK plc is a leading global healthcare company that researches, develops, and manufactures innovative pharmaceutical and consumer healthcare products. This company primarily focuses on creating vaccin...

GSK Waste Data Preview

In 2023, GSK conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2024202320222021 - 2017
Total Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Waste Recovered
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Non-Hazardous Waste Disposed
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.

Insights into GSK's Waste Treatment Practices

In 2023, GSK generated a total of 49,700 metric tonnes of waste.

Of this amount, 52.72% of GSK's total waste generated was recovered through methods such as recycling, reuse, or composting, while 47.28% was disposed of through landfilling, incineration, or combustion.

GSK's Waste Recovery Rate

53%

How much of GSK's waste is recycled or recovered?

In 2023, GSK reported a total waste generation of 49,700 metric tonnes, of which 52.72% was recovered through recycling, reuse, or composting. This moderate level of recovery indicates that GSK is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.

Has GSK reduced its environmental waste footprint over time?

Since 2020, GSK's total waste generation decreased by 21.11%, including a further 1.19% drop in 2023, highlighting a consistent and deliberate reduction in waste production over time.

Over the same period, GSK's waste recovery rate increased by 21.63%.

GSK’s Waste Recovery vs. Disposal Over Time

202120222023015 k30 k45 k60 ktonnes
  • Total Waste Disposed
  • Total Waste Recovered

Insights into GSK’s Generation of Hazardous and Non-Hazardous Waste

In 2023, GSK generated a total of 49,700 metric tonnes of waste.

Of this amount, 36.82% of GSK's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 63.18% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.

GSK’s Hazardous vs Non-Hazardous Waste Over Time

2020202120222023020 k40 k60 k80 ktonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How GSK reduced the environmental impact of its waste?

Since 2020, GSK's total waste generation decreased by 21.11%, with an additional 1.19% decline in 2023, suggesting a consistent and deliberate effort to minimize waste generation at the source.

Over the same period, GSK reduced the hazardousness of its waste by 9.74%, with a further 3.54% decline in 2023, suggesting a sustained and meaningful shift toward safer waste profiles and lower environmental impact.

Overall, GSK has made consistent and substantial progress in reducing both the quantity and the danger of its waste, highlighting a strong, well-executed waste strategy focused on minimizing environmental impact.

How does GSK treat its hazardous waste?

In 2023, GSK reported that 18,300 metric tonnes of its total waste output were classified as hazardous. This represents 36.82% of its overall waste generation.

The company treated this hazardous waste using a combination of methods. Approximately 19.67% was managed through recovery methods, indicating a moderate integration of circular practices into its hazardous waste management. However, a significant share was still directed toward disposal, highlighting room for improvement in reducing the long-term impact of hazardous materials.

Breakdown of GSK's Hazardous and Non-Hazardous Waste by Treatment Method

Hazardous WasteDisposed(29.6%)Hazardous WasteRecovered(7.2%)Non-Hazardous WasteDisposed(17.9%)Non-Hazardous WasteRecovered(45.3%)
Want Full Access to GSK's Waste Management Dataset?
Sign Up